← Eichor
Study identifier: NCT04948749 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Drug Eluting Stenting and Aggressive Medical Treatment for Preventing Recurrent Stroke in Intracranial Atherosclerotic Disease Trial

Condition: ICAD - Intracranial Atherosclerotic Disease · ICAS - Intracranial Atherosclerosis · Drug-eluting Stent  ·  Sponsor: Beijing Tiantan Hospital

PhaseNA
Planned participants358
Who can joinAll sexes, 18 Years to 85 Years
Healthy volunteersNo

About this study

The aim of DREAM-PRIDE is to evaluate whether implantation of drug-eluting stent (DES) combined with aggressive medical treatment is more efficacious in prevention of 1-year stroke recurrence than standard medical treatment alone for symptomatic intracranial atherosclerotic disease.

This description comes directly from the study's public registry record.

Talk to the study team

Ning Ma, MD  ·  13581889908  ·  maning_03@hotmail.com

Baixue Jia, MD  ·  15010125093  ·  beckyberry@163.com

Always discuss trial participation with your own doctor first.

Locations (18)

Beijing Tiantan HospitalBeijing, Beijing Municipality, ChinaRecruiting
Beijing Daxing District People's HospitalBeijing, Beijing Municipality, ChinaRecruiting
Hejian People's HospitalCangzhou, Hebei, ChinaRecruiting
North China University of Science and Technology Affiliated HospitalTangshan, Hebei, ChinaRecruiting
Xingtai City Third HospitalXingtai, Hebei, ChinaRecruiting
General Hospital of The Yangtze River ShippingWuhan, Hubei, ChinaRecruiting
Baotou Central HospitalBaotou, Inner Mongolia, ChinaRecruiting
Inner Mongolia Autonomous Region People's HospitalHohhot, Inner Mongolia, ChinaRecruiting
Tongliao City HospitalTongliao, Inner Mongolia, ChinaRecruiting
Wuhai People's HospitalWuhai, Inner Mongolia, ChinaRecruiting
The Second Affiliated Hospital of Nanjing Medical UniversityNanjing, Jiangsu, ChinaRecruiting
The Second Norman Bethune Hospital of JilinUniversity,Changchun, Jilin, ChinaRecruiting

+ 6 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04948749